We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

59 hedge funds and large institutions have $60.2M invested in abrdn Life Sciences Investors in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

56% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 16

5% more funds holding

Funds holding: 56 → 59 (+3)

0.46% less ownership

Funds ownership: 15.02% → 14.56% (-0.46%)

1% less capital invested

Capital invested by funds: $61M → $60.2M (-$713K)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
59
Holders Change
+3
Holders Change %
+5.36%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
25
Reduced
16
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
William Blair & Company
William Blair & Company
Illinois
+$1.05M
2
Invesco
Invesco
Georgia
+$669K
3
RJA
Raymond James & Associates
Florida
+$551K
4
NMC
Nine Masts Capital
Hong Kong
+$457K
5
DA
Doliver Advisors
Texas
+$357K

Top Sellers

Rank Fund Capital Flow
1
CAN
Claraphi Advisory Network
United States
-$2.64M
2
Morgan Stanley
Morgan Stanley
New York
-$583K
3
Cerity Partners
Cerity Partners
New York
-$192K
4
LPL Financial
LPL Financial
California
-$159K
5
AG
Advisor Group
Arizona
-$128K
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$13K +$565 +30 +4%
GAM
52
Gemmer Asset Management
California
$12K +$19 +1 +0.2%
AF
53
Advisornet Financial
Minnesota
$12K +$245 +13 +2%
FIA
54
FNY Investment Advisers
New York
$12K +$12.7K +675 New
BC
55
Barnett & Company
Tennessee
$10K – – –
MSFP
56
Mark Sheptoff Financial Planning
Connecticut
$9K – – –
CAC
57
Certified Advisory Corp
Florida
$9K +$169 +9 +2%
SEI Investments
58
SEI Investments
Pennsylvania
$9K +$376 +20 +4%
AWM
59
Aevitas Wealth Management
Massachusetts
$1K – – –
Cerity Partners
60
Cerity Partners
New York
– -$192K -10,000 Closed
PMFA
61
Plante Moran Financial Advisors
Michigan
– -$32K -1,670 Closed
NSIM
62
North Star Investment Management
Illinois
– -$27K -1,415 Closed
SWP
63
Stratos Wealth Partners
Ohio
– -$15K -798 Closed
CAGAS
64
Capital Advisory Group Advisory Services
Minnesota
– -$5K -255 Closed
1 2
3

HQL Hedge Fund Activity: Q2 2018 in Review

59 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q2 2018, worth a combined $60.2M — down 1.2% from $61M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new HQL positions and 5 closed out — a net gain of 3 holders — while 25 added to existing stakes and 16 trimmed.

The largest buyer was William Blair & Company, opening a new position worth an estimated $1.05M. The largest seller was Claraphi Advisory Network, cutting an estimated $2.64M.

  • 59 institutional investors held abrdn Life Sciences Investors (HQL) as of Q2 2018, up from 56 in Q1 2018.
  • Funds reported $60.2M of abrdn Life Sciences Investors stock for Q2 2018, down 1.2% quarter-over-quarter.
  • 8 funds opened new abrdn Life Sciences Investors positions in Q2 2018 and 5 closed out, a net change of +3 holders.
  • The largest abrdn Life Sciences Investors buyer in Q2 2018 was William Blair & Company, an estimated $1.05M added.
  • The largest abrdn Life Sciences Investors seller in Q2 2018 was Claraphi Advisory Network, an estimated $2.64M sold.

Based on aggregated 13F filings for Q2 2018.